HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
HESX1
HESX homeobox 1
Chromosome 3 Β· 3p14.3
NCBI Gene: 8820Ensembl: ENSG00000163666.11HGNC: HGNC:4877UniProt: Q9UBX0
51PubMed Papers
23Diseases
0Drugs
21Pathogenic Variants
FUNCTIONAL ROLE
Transcription Factor
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
gene expressionRNA polymerase II transcription regulatory region sequence-specific DNA bindingRNA polymerase II cis-regulatory region sequence-specific DNA bindingDNA-binding transcription repressor activity, RNA polymerase II-specificseptooptic dysplasiaCombined pituitary hormone deficiencies, genetic formsSepto-optic dysplasiapituitary hormone deficiency, combined, 1
✦AI Summary

HESX1 is a homeobox transcription factor essential for anterior forebrain, pituitary, and midline structure development 1. During embryogenesis, HESX1 is expressed in prospective forebrain tissue and becomes restricted to Rathke's pouch, the anterior pituitary primordium, until approximately E15.5 in mice 2. The protein functions as a sequence-specific DNA-binding transcription repressor that binds palindromic PIII sequences and forms heterodimers with PROP1 to antagonize PROP1 activation 3. Notably, HESX1 expression persists in adult human pituitaries, suggesting an ongoing role in pituitary cell maintenance and function 2. Loss-of-function HESX1 mutations cause septo-optic dysplasia (SOD), characterized by optic nerve hypoplasia, midline defects (agenesis of septum pellucidum, corpus callosum abnormalities), and pituitary hormone deficiencies 14. Missense mutations within the homeodomain that abolish DNA-binding capacity have been documented in familial SOD cases 1. HESX1 mutations also contribute to combined pituitary hormone deficiency and hypogonadotropic hypogonadism through disrupted hypothalamic-pituitary axis development 5. Recent evidence implicates HESX1 in monogenic absence seizure epilepsies, though the mechanistic link remains unclear 6. The variable penetrance and expressivity of HESX1-related disorders likely reflect contributions from both genetic and environmental factors 7.

Sources cited
1
HESX1 is a transcription factor involved in pituitary development with well-characterized clinical and molecular mechanisms
PMID: 28476222
2
HESX1 mutations cause septo-optic dysplasia with anterior CNS and pituitary defects; Arg53Cys mutation abolishes DNA binding
PMID: 9620767
3
HESX1 is expressed in forebrain tissue and Rathke's pouch; missense mutations in the homeodomain impair DNA binding in familial septo-optic dysplasia
PMID: 10626545
4
HESX1 is expressed during embryogenesis and persists in adult human pituitaries, suggesting roles in pituitary maintenance and function
PMID: 16414177
5
HESX1 mutations contribute to hypogonadotropic hypogonadism through defective hypothalamic-pituitary axis development
PMID: 12536356
6
HESX1 mutations are implicated in septo-optic dysplasia and other midline disorders with variable phenotypes
PMID: 21396578
7
HESX1 is newly associated with monogenic epilepsies featuring absence seizures
PMID: 41137852
Disease Associationsβ“˜23
septooptic dysplasiaOpen Targets
0.83Strong
Combined pituitary hormone deficiencies, genetic formsOpen Targets
0.81Strong
Septo-optic dysplasiaOpen Targets
0.79Strong
pituitary hormone deficiency, combined, 1Open Targets
0.47Moderate
genetic disorderOpen Targets
0.47Moderate
combined pituitary hormone deficiencies, genetic formOpen Targets
0.47Moderate
pituitary stalk interruption syndromeOpen Targets
0.37Weak
Kallmann syndromeOpen Targets
0.37Weak
hypothyroidism due to deficient transcription factors involved in pituitary development or functionOpen Targets
0.37Weak
Male infertility with spermatogenesis disorderOpen Targets
0.27Weak
amenorrheaOpen Targets
0.11Weak
Isolated anophthalmia - microphthalmiaOpen Targets
0.10Weak
microphthalmiaOpen Targets
0.10Weak
nanophthalmiaOpen Targets
0.10Suggestive
isolated microphthalmia 7Open Targets
0.10Suggestive
nanophthalmos 2Open Targets
0.10Suggestive
Microphthalmia - ankyloblepharon - intellectual disabilityOpen Targets
0.08Suggestive
microphthalmia, isolated, with coloboma 5Open Targets
0.08Suggestive
microphthalmia, isolated, with colobomaOpen Targets
0.07Suggestive
microphthalmia, isolated, with coloboma 10Open Targets
0.07Suggestive
Growth hormone deficiency with pituitary anomaliesUniProt
Pituitary hormone deficiency, combined, 5UniProt
Septooptic dysplasiaUniProt
Pathogenic Variants21
NM_003865.3(HESX1):c.349C>T (p.Gln117Ter)Pathogenic
Septo-optic dysplasia sequence|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 117
NM_003865.3(HESX1):c.308T>A (p.Leu103Ter)Likely pathogenic
Septo-optic dysplasia sequence|Pituitary hormone deficiency, combined, 1|not provided
β˜…β˜…β˜†β˜†2019β†’ Residue 103
NM_003865.3(HESX1):c.357+1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2025
NM_003865.3(HESX1):c.48del (p.Ser17fs)Likely pathogenic
Septo-optic dysplasia sequence
β˜…β˜†β˜†β˜†2025β†’ Residue 17
NM_003865.3(HESX1):c.478C>T (p.Arg160Cys)Pathogenic
Septo-optic dysplasia sequence|GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES;Septo-optic dysplasia sequence
β˜…β˜†β˜†β˜†2024β†’ Residue 160
NM_003865.3(HESX1):c.99del (p.Asp34fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 34
NM_003865.3(HESX1):c.389del (p.Asn130fs)Pathogenic
GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES;Septo-optic dysplasia sequence
β˜…β˜†β˜†β˜†2022β†’ Residue 130
NM_003865.3(HESX1):c.254C>A (p.Ser85Ter)Pathogenic
Inborn genetic diseases
β˜…β˜†β˜†β˜†2022β†’ Residue 85
NM_003865.3(HESX1):c.305_306del (p.Glu102fs)Pathogenic
GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES;Septo-optic dysplasia sequence
β˜…β˜†β˜†β˜†2022β†’ Residue 102
NM_003865.3(HESX1):c.135G>A (p.Trp45Ter)Pathogenic
Septo-optic dysplasia sequence;GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES
β˜…β˜†β˜†β˜†2022β†’ Residue 45
NM_003865.3(HESX1):c.173del (p.Leu58fs)Pathogenic
Septo-optic dysplasia sequence;GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES
β˜…β˜†β˜†β˜†2022β†’ Residue 58
NM_003865.3(HESX1):c.241G>T (p.Glu81Ter)Pathogenic
Septo-optic dysplasia sequence;GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES
β˜…β˜†β˜†β˜†2022β†’ Residue 81
NM_003865.3(HESX1):c.325C>T (p.Arg109Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2019β†’ Residue 109
NM_003865.3(HESX1):c.106_107del (p.Val36fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2017β†’ Residue 36
NM_003865.3(HESX1):c.158-1G>CLikely pathogenic
GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES;Septo-optic dysplasia sequence
β˜…β˜†β˜†β˜†2017
NM_003865.3(HESX1):c.240del (p.Glu81fs)Pathogenic
Septo-optic dysplasia sequence|Pituitary hormone deficiency, combined, 1
β˜†β˜†β˜†β˜†2010β†’ Residue 81
NM_003865.3(HESX1):c.357+2T>CPathogenic
PITUITARY HORMONE DEFICIENCY, COMBINED, 5
β˜†β˜†β˜†β˜†2006
NM_003865.3(HESX1):c.450_451del (p.Asp150fs)Pathogenic
PITUITARY HORMONE DEFICIENCY, COMBINED, 5
β˜†β˜†β˜†β˜†2006β†’ Residue 150
NM_003865.3(HESX1):c.525del (p.Asn178fs)Pathogenic
Septo-optic dysplasia sequence
β˜†β˜†β˜†β˜†2003β†’ Residue 178
NM_003865.3(HESX1):c.77T>C (p.Ile26Thr)Pathogenic
PITUITARY HORMONE DEFICIENCY, COMBINED, 5
β˜†β˜†β˜†β˜†2003β†’ Residue 26
View on ClinVar β†—
Related Genes
POU1F1Protein interaction95%SOX3Protein interaction77%TLE1Protein interaction73%PROKR2Protein interaction71%SOX2Protein interaction50%TBR1Shared pathway25%
Tissue Expression6 tissues
Bone Marrow
100%
Liver
33%
Ovary
22%
Heart
13%
Lung
11%
Brain
7%
Gene Interaction Network
Click a node to explore
HESX1POU1F1SOX3TLE1PROKR2SOX2TBR1
PROTEIN STRUCTURE
Preparing viewer…
PDB2K40 Β· NMR
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.84LoF Tolerant
pLIβ“˜
0.12Tolerant
Observed/Expected LoF0.47 [0.27–0.84]
RankingsWhere HESX1 stands among ~20K protein-coding genes
  • #8,686of 20,598
    Most Researched51
  • #2,158of 5,498
    Most Pathogenic Variants21
  • #7,228of 17,882
    Most Constrained (LOEUF)0.84
Genes detectedHESX1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Pituitary Hypoplasia.
PMID: 28476222
Endocrinol Metab Clin North Am Β· 2017
1.00
2
Hypogonadotropic hypogonadism.
PMID: 12536356
Semin Reprod Med Β· 2002
0.90
3
HESX1 and Septo-Optic Dysplasia.
PMID: 12424431
Rev Endocr Metab Disord Β· 2002
0.80
4
Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse.
PMID: 9620767
Nat Genet Β· 1998
0.70
5
Septo-optic dysplasia.
PMID: 21037540
Pediatr Endocrinol Rev Β· 2010
0.60